Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis

Background: Disease-modifying drugs (DMDs) for multiple sclerosis (MS) slightly increase the risk of tuberculosis (TB) disease. The QuantiFERON-TB-Plus (QFT-Plus) test is approved for TB infection (TBI) screening. Currently, there are no data available regarding the characterization of QFT-Plus resp...

Description complète

Détails bibliographiques

Auteurs principaux:	Elisa Petruccioli, Luca Prosperini, Serena Ruggieri, Valentina Vanini, Andrea Salmi, Gilda Cuzzi, Simonetta Galgani, Shalom Haggiag, Carla Tortorella, Gabriella Parisi, Alfio D’Agostino, Gina Gualano, Fabrizio Palmieri, Claudio Gasperini, Delia Goletti
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2025-08-01
Collection:	Neurology International
Sujets:	QFT-Plus IFN-γ multiple sclerosis MS tuberculosis
Accès en ligne:	https://www.mdpi.com/2035-8377/17/8/119
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!